We are live on
!
Find out more
BCM
Boltwood Capital Management Portfolio holdings
AUM
$436M
1-Year Est. Return
24%
This Fund
S&P 500
This Quarter
Est. Return
+4.89%
1 Year Est. Return
+24%
3 Year Est. Return
+56.3%
5 Year Est. Return
+58.63%
10 Year Est. Return
+204.35%
AUM
$143M
AUM Growth
+$12.1M
(+9.2%)
Cap. Flow
+$6.43M
Cap. Flow
% of AUM
4.5%
Top 10 Holdings %
Top 10 Hldgs %
31.31%
Holding
114
New
7
Increased
62
Reduced
15
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$912K |
| 2 |
Cencora
COR
|
+$658K |
| 3 |
Abbott
ABT
|
+$575K |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$438K |
| 5 |
Schwab International Equity ETF
SCHF
|
+$354K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$876K |
| 2 |
Merck
MRK
|
+$645K |
| 3 |
McKesson
MCK
|
+$613K |
| 4 |
Pfizer
PFE
|
+$204K |
| 5 |
Xerox
XRX
|
+$185K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.61% |
| 2 | Financials | 11.68% |
| 3 | Technology | 10.98% |
| 4 | Energy | 6.86% |
| 5 | Consumer Staples | 6.43% |
Similar funds
TECP
ACG
VDBMI
VIM
NF
SCP
SWG
VBA
Boltwood Capital Management's Q1 2017 Portfolio in Review
As of Q1 2017, Boltwood Capital Management held 114 positions worth $143M, up 9.2% from $131M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Boltwood Capital Management deployed $6.43M of net new capital in Q1 2017, opening 7 new positions and adding to 62 existing holdings. Its largest new stake was Allergan plc: 3,915 shares worth $935K.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Merck, an estimated $645K trimmed.
- Boltwood Capital Management's largest Q1 2017 buy was Allergan plc: 3,915 shares worth $935K.
- Boltwood Capital Management added most to Abbott in Q1 2017, an estimated $575K increase.
- Boltwood Capital Management's biggest Q1 2017 reduction was Merck, cutting an estimated $645K.
- Boltwood Capital Management fully exited St Jude Medical in Q1 2017, selling an estimated $876K.
- Boltwood Capital Management's ten largest holdings make up 31% of its $143M portfolio in Q1 2017.
- Boltwood Capital Management opened 7 new positions and closed 2 in Q1 2017.
- Boltwood Capital Management's portfolio value rose 9.2% quarter-over-quarter to $143M.
Based on Boltwood Capital Management's 13F filing for Q1 2017, filed 6 Apr 2017.